Fig. 2: IDentif.AI-x interaction analysis. | npj Digital Medicine

Fig. 2: IDentif.AI-x interaction analysis.

From: The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimens

Fig. 2

The analysis indicates that EIDD-1931 interacts differently with remdesivir (RDV) and baricitinib (BRT). EIDD-1931/remdesivir interaction surface had a convex shape indicating a synergistic interaction, while EIDD-1931/baricitinib interaction surface had a concave shape indicating a dose-dependent, mildly antagonistic interaction. L0, L1, and L2 correspond to concentration Level 0, Level 1, and Level 2.

Back to article page